Adenovirus Dodecahedron, a VLP, Can be Purified by Size Exclusion Chromatography Instead of Time-Consuming Sucrose Density Gradient Centrifugation

Molecular Biotechnology

Volumn 57, Issue 6, 2015, Pages 565-573

  Szurgot, I ^a   Jedynak, M ^a   Podsiadla Bialoskorska, M ^a   Piwowarski, Jan ^a   Szolajska, E ^a   Chroboczek, J ^a,b  

^a INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^b CNRS   (France)

Author keywords

Drug delivery vector; Expression system; Improved baculovirus; Large protein expression; Purification protocol; Virus like particle

Indexed keywords

CELLS; CYTOLOGY; DRUG DELIVERY; GENE EXPRESSION; LEAD; PROTEINS; PURIFICATION; VACCINES; VIRUSES;

BACULOVIRUS; DELIVERY VECTOR; EXPRESSION SYSTEM; PROTEIN EXPRESSIONS; PURIFICATION PROTOCOL; VIRUS-LIKE PARTICLES;

SIZE EXCLUSION CHROMATOGRAPHY;

SUCROSE; VIRUS PROTEIN;

ADENOVIRIDAE; CENTRIFUGATION; ESCHERICHIA COLI; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; PROCEDURES; SIZE EXCLUSION CHROMATOGRAPHY; VIRUS GENE;

ADENOVIRIDAE; CENTRIFUGATION; CHROMATOGRAPHY, GEL; CLONING, MOLECULAR; ESCHERICHIA COLI; GENES, VIRAL; SUCROSE; VIRAL PROTEINS;

EID: 84939955537     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-015-9850-9     Document Type: Article

References (20)

1. Wickham, T. J., Mathias, P., Cheresh, D. A., & Nemerow, G. R. (1993). Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell,73(2), 309–319.
2. Fender, P., Ruigrok, R. W., Gout, E., Buffet, S., & Chroboczek, J. (1997). Adenovirus dodecahedron, a new vector for human gene transfer. Nature Biotechnology,15(1), 52–56.
3. Fender, P., Schoehn, G., Foucaud-Gamen, J., Gout, E., Garcel, A., Drouet, E., & Chroboczek, J. (2003). Adenovirus dodecahedron allows large multimeric protein in human cells. Journal of Virology,77(8), 4960–4964.
4. Garcel, A., Gout, E., Timmins, J., Chroboczek, J., & Fender, P. (2006). Protein transduction into human cells by adenovirus dodecahedron using WW domains as universal adaptors. Journal of Gene Medicine,8(4), 524–531.
5. Szolajska, E., Burmeister, W. P., Zochowska, M., Nerlo, B., Andreev, I., Schoehn, G., et al. (2012). The structural basis for the integrity of adenovirus Ad3 dodecahedron. PLoS One,7(9), e46075.
6. Zochowska, M., Paca, A., Schoehn, G., Andrieu, J. P., Chroboczek, J., Dublet, B., & Szolajska, E. (2009). Adenovirus dodecahedron, as a drug delivery vector. PLoS One,4, e5569.
7. Zochowska, M., Piguet, A. C., Jemielity, J., Kowalska, J., Szolajska, E., Dufour, J. F., & Chroboczek, J. (2014). Virus-like particle-mediated intracellular delivery of mRNA cap analog with in vivo activity against hepatocellular carcinoma. Nanomedicine,S1549–9634(14), 00419.
8. Szurgot, I., Szolajska, E., Laurin, D., Lambrecht, B., Chaperot, L., Schoehn, G., & Chroboczek, J. (2013). Self-adjuvanting influenza candidate vaccine presenting epitopes for cell-mediated immunity on a proteinaceous multivalent nanoplatform. Vaccine,31(40), 4338–4346.
9. Gallegos, C. O., & Patton, J. T. (1989). Characterization of rotavirus replication intermediates: A model for the assembly of single-shelled particles. Virology,172(2), 616–627.
10. Hitchman, R. B., Possee, R. D., Siaterli, E., Richards, K. S., Clayton, A. J., Bird, L. E., et al. (2010). Improved expression of secreted and membrane-targeted proteins in insect cells. Biotechnology and Applied Biochemistry,56(3), 85–93.
11. Urbas, L., Lah Jarc, B., Barut, M., Zochowska, M., Chroboczek, J., Pihlar, B., & Szolajska, E. (2011). Purification of recombinant adenovirus type 3 dodecahedric virus-like particles for biomedical applications using short monolithic columns. Journal of Chromatography A,1218(17), 2451–2459.
12. Naskalska, A., Szolajska, E., Chaperot, L., Angel, J., Plumas, J., & Chroboczek, J. (2009). Influenza recombinant vaccine: Matrix protein M1 on the platform of the adenovirus dodecahedron. Vaccine,27(52), 7385–7393.
13. Savard, C., Laliberté-Gagné, M. È., Babin, C., Bolduc, M., Guérin, A., Drouin, K., et al. (2012). Improvement of the PapMV nanoparticle adjuvant property through an increase of its avidity for the antigen [influenza NP]. Vaccine,30(15), 2535–2542.
14. Teunissen, E. A., de Raad, M., & Mastrobattista, E. (2013). Production and biomedical applications of virus-like particles derived from polyomaviruses. Journal of Controlled Release,172(1), 305–321.
15. Wei, M. X., Zhang, X., Yu, H., Tang, Z. M., Wang, K. H., Li, Z. Y., et al. (2014). Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes. Vaccine,32(24), 2859–2865.
16. +-triggered switch in the thermodynamic attraction between structural protein capsomeres. Journal of the Royal Society, Interface,7(44), 409–421.
17. Liew, M. W. O., Chuan, Y. P., & Middelberg, A. P. J. (2012). High-yield and scalable cellfree assembly of virus-like particles by dilution. Biochemical Engineering Journal,67, 88–96.
18. Simon, C., Klose, T., Herbst, S., Han, B. G., Sinz, A., Glaeser, R. M., et al. (2014). Disulfide linkage and structure of highly stable yeast-derived virus-like particles of murine polyomavirus. Journal of Biological Chemistry,289(15), 10411–10418.
19. Fender, P., Boussaid, A., Mezin, P., & Chroboczek, J. (2005). Synthesis, cellular localization, and quantification of penton-dodecahedron in serotype 3 adenovirus-infected cells. Virology,340(2), 167–173.
20. Vicente, T., Roldão, A., Peixoto, C., Carrondo, M. J., & Alves, P. M. (2011). Large-scale production and purification of VLP-based vaccines. Journal of Invertebrate Pathology,107(Suppl), S42–488. Review.